nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—PDE8B—forelimb—amyotrophic lateral sclerosis	0.0236	0.0746	CbGeAlD
Dipyridamole—PDE8B—hindlimb—amyotrophic lateral sclerosis	0.0212	0.0671	CbGeAlD
Dipyridamole—Rectal tenesmus—Riluzole—amyotrophic lateral sclerosis	0.0187	0.0452	CcSEcCtD
Dipyridamole—PDE8B—appendage—amyotrophic lateral sclerosis	0.0182	0.0575	CbGeAlD
Dipyridamole—Proctalgia—Riluzole—amyotrophic lateral sclerosis	0.0148	0.0359	CcSEcCtD
Dipyridamole—Renal pain—Riluzole—amyotrophic lateral sclerosis	0.0132	0.032	CcSEcCtD
Dipyridamole—PDE2A—tongue—amyotrophic lateral sclerosis	0.0132	0.0418	CbGeAlD
Dipyridamole—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0127	0.0308	CcSEcCtD
Dipyridamole—Supraventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0257	CcSEcCtD
Dipyridamole—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0245	CcSEcCtD
Dipyridamole—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.00993	0.024	CcSEcCtD
Dipyridamole—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00909	0.022	CcSEcCtD
Dipyridamole—PDE1A—hindbrain—amyotrophic lateral sclerosis	0.00842	0.0266	CbGeAlD
Dipyridamole—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00798	0.0193	CcSEcCtD
Dipyridamole—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.00771	0.0187	CcSEcCtD
Dipyridamole—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.00771	0.0187	CcSEcCtD
Dipyridamole—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00709	0.0172	CcSEcCtD
Dipyridamole—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00696	0.0169	CcSEcCtD
Dipyridamole—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.00692	0.0168	CcSEcCtD
Dipyridamole—PDE6B—medulla oblongata—amyotrophic lateral sclerosis	0.00671	0.0212	CbGeAlD
Dipyridamole—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.0062	0.015	CcSEcCtD
Dipyridamole—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.0061	0.0148	CcSEcCtD
Dipyridamole—PDE6B—spinal cord—amyotrophic lateral sclerosis	0.00598	0.0189	CbGeAlD
Dipyridamole—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00592	0.0143	CcSEcCtD
Dipyridamole—PDE1C—nervous system—amyotrophic lateral sclerosis	0.00588	0.0186	CbGeAlD
Dipyridamole—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00578	0.014	CcSEcCtD
Dipyridamole—PDE1C—central nervous system—amyotrophic lateral sclerosis	0.00566	0.0179	CbGeAlD
Dipyridamole—PDE1C—cerebellum—amyotrophic lateral sclerosis	0.00553	0.0175	CbGeAlD
Dipyridamole—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00538	0.013	CcSEcCtD
Dipyridamole—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00533	0.0129	CcSEcCtD
Dipyridamole—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00531	0.0129	CcSEcCtD
Dipyridamole—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00522	0.0126	CcSEcCtD
Dipyridamole—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.0052	0.0126	CcSEcCtD
Dipyridamole—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00505	0.0122	CcSEcCtD
Dipyridamole—PDE6B—nervous system—amyotrophic lateral sclerosis	0.00504	0.0159	CbGeAlD
Dipyridamole—PRUNE—cerebellum—amyotrophic lateral sclerosis	0.00499	0.0158	CbGeAlD
Dipyridamole—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00497	0.012	CcSEcCtD
Dipyridamole—PDE6B—central nervous system—amyotrophic lateral sclerosis	0.00485	0.0153	CbGeAlD
Dipyridamole—PDE1A—brainstem—amyotrophic lateral sclerosis	0.00483	0.0152	CbGeAlD
Dipyridamole—PDE6D—cerebellum—amyotrophic lateral sclerosis	0.00482	0.0152	CbGeAlD
Dipyridamole—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00481	0.0116	CcSEcCtD
Dipyridamole—PDE6B—cerebellum—amyotrophic lateral sclerosis	0.00474	0.015	CbGeAlD
Dipyridamole—PDE6H—nervous system—amyotrophic lateral sclerosis	0.00468	0.0148	CbGeAlD
Dipyridamole—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00462	0.0112	CcSEcCtD
Dipyridamole—PDE6H—central nervous system—amyotrophic lateral sclerosis	0.00451	0.0142	CbGeAlD
Dipyridamole—PDE1C—brain—amyotrophic lateral sclerosis	0.00449	0.0142	CbGeAlD
Dipyridamole—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00437	0.0106	CcSEcCtD
Dipyridamole—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00426	0.0103	CcSEcCtD
Dipyridamole—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00419	0.0101	CcSEcCtD
Dipyridamole—PDE7A—nervous system—amyotrophic lateral sclerosis	0.00418	0.0132	CbGeAlD
Dipyridamole—PDE2A—medulla oblongata—amyotrophic lateral sclerosis	0.00405	0.0128	CbGeAlD
Dipyridamole—PRUNE—brain—amyotrophic lateral sclerosis	0.00405	0.0128	CbGeAlD
Dipyridamole—PDE7A—central nervous system—amyotrophic lateral sclerosis	0.00402	0.0127	CbGeAlD
Dipyridamole—PDE6D—brain—amyotrophic lateral sclerosis	0.00391	0.0124	CbGeAlD
Dipyridamole—PDE6B—brain—amyotrophic lateral sclerosis	0.00385	0.0122	CbGeAlD
Dipyridamole—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00384	0.00929	CcSEcCtD
Dipyridamole—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00382	0.00924	CcSEcCtD
Dipyridamole—PDE7B—nervous system—amyotrophic lateral sclerosis	0.00365	0.0115	CbGeAlD
Dipyridamole—PDE2A—spinal cord—amyotrophic lateral sclerosis	0.00361	0.0114	CbGeAlD
Dipyridamole—PDE6H—brain—amyotrophic lateral sclerosis	0.00358	0.0113	CbGeAlD
Dipyridamole—PDE11A—brain—amyotrophic lateral sclerosis	0.00358	0.0113	CbGeAlD
Dipyridamole—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00356	0.00861	CcSEcCtD
Dipyridamole—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00351	0.00851	CcSEcCtD
Dipyridamole—PDE7B—central nervous system—amyotrophic lateral sclerosis	0.00351	0.0111	CbGeAlD
Dipyridamole—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00351	0.00848	CcSEcCtD
Dipyridamole—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.0035	0.00846	CcSEcCtD
Dipyridamole—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0035	0.00846	CcSEcCtD
Dipyridamole—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00348	0.00842	CcSEcCtD
Dipyridamole—PDE8A—medulla oblongata—amyotrophic lateral sclerosis	0.00348	0.011	CbGeAlD
Dipyridamole—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00347	0.0084	CcSEcCtD
Dipyridamole—PDE1A—medulla oblongata—amyotrophic lateral sclerosis	0.00337	0.0106	CbGeAlD
Dipyridamole—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00324	0.00785	CcSEcCtD
Dipyridamole—PDE7A—brain—amyotrophic lateral sclerosis	0.00319	0.0101	CbGeAlD
Dipyridamole—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00317	0.00768	CcSEcCtD
Dipyridamole—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00764	CcSEcCtD
Dipyridamole—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00315	0.00763	CcSEcCtD
Dipyridamole—Chills—Riluzole—amyotrophic lateral sclerosis	0.00314	0.00759	CcSEcCtD
Dipyridamole—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00312	0.00756	CcSEcCtD
Dipyridamole—PDE8A—spinal cord—amyotrophic lateral sclerosis	0.0031	0.00979	CbGeAlD
Dipyridamole—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00309	0.00748	CcSEcCtD
Dipyridamole—PDE2A—nervous system—amyotrophic lateral sclerosis	0.00305	0.00962	CbGeAlD
Dipyridamole—PDE10A—nervous system—amyotrophic lateral sclerosis	0.00305	0.00962	CbGeAlD
Dipyridamole—PDE1B—nervous system—amyotrophic lateral sclerosis	0.00302	0.00953	CbGeAlD
Dipyridamole—PDE1A—spinal cord—amyotrophic lateral sclerosis	0.003	0.00948	CbGeAlD
Dipyridamole—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.003	0.00726	CcSEcCtD
Dipyridamole—Tension—Riluzole—amyotrophic lateral sclerosis	0.00299	0.00723	CcSEcCtD
Dipyridamole—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00298	0.00721	CcSEcCtD
Dipyridamole—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00296	0.00715	CcSEcCtD
Dipyridamole—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00713	CcSEcCtD
Dipyridamole—PDE2A—central nervous system—amyotrophic lateral sclerosis	0.00293	0.00926	CbGeAlD
Dipyridamole—PDE10A—central nervous system—amyotrophic lateral sclerosis	0.00293	0.00926	CbGeAlD
Dipyridamole—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00708	CcSEcCtD
Dipyridamole—PDE1B—central nervous system—amyotrophic lateral sclerosis	0.00291	0.00918	CbGeAlD
Dipyridamole—PDE8B—nervous system—amyotrophic lateral sclerosis	0.00291	0.00917	CbGeAlD
Dipyridamole—PDE10A—cerebellum—amyotrophic lateral sclerosis	0.00287	0.00905	CbGeAlD
Dipyridamole—PDE2A—cerebellum—amyotrophic lateral sclerosis	0.00287	0.00905	CbGeAlD
Dipyridamole—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00285	0.0069	CcSEcCtD
Dipyridamole—PDE1B—cerebellum—amyotrophic lateral sclerosis	0.00284	0.00897	CbGeAlD
Dipyridamole—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00282	0.00684	CcSEcCtD
Dipyridamole—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00281	0.00681	CcSEcCtD
Dipyridamole—PDE8B—central nervous system—amyotrophic lateral sclerosis	0.0028	0.00883	CbGeAlD
Dipyridamole—PDE7B—brain—amyotrophic lateral sclerosis	0.00279	0.00881	CbGeAlD
Dipyridamole—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00278	0.00673	CcSEcCtD
Dipyridamole—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00664	CcSEcCtD
Dipyridamole—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00273	0.00662	CcSEcCtD
Dipyridamole—PDE8B—cerebellum—amyotrophic lateral sclerosis	0.00273	0.00863	CbGeAlD
Dipyridamole—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00273	0.00661	CcSEcCtD
Dipyridamole—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00651	CcSEcCtD
Dipyridamole—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00268	0.00647	CcSEcCtD
Dipyridamole—PDE3B—cerebellum—amyotrophic lateral sclerosis	0.00267	0.00843	CbGeAlD
Dipyridamole—Cough—Riluzole—amyotrophic lateral sclerosis	0.00266	0.00643	CcSEcCtD
Dipyridamole—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00264	0.00638	CcSEcCtD
Dipyridamole—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00263	0.00636	CcSEcCtD
Dipyridamole—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00259	0.00627	CcSEcCtD
Dipyridamole—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00259	0.00627	CcSEcCtD
Dipyridamole—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00259	0.00627	CcSEcCtD
Dipyridamole—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00258	0.00625	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00257	0.00623	CcSEcCtD
Dipyridamole—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00256	0.0062	CcSEcCtD
Dipyridamole—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00613	CcSEcCtD
Dipyridamole—PDE1A—nervous system—amyotrophic lateral sclerosis	0.00253	0.00799	CbGeAlD
Dipyridamole—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00248	0.00601	CcSEcCtD
Dipyridamole—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00248	0.00601	CcSEcCtD
Dipyridamole—PDE8A—cerebellum—amyotrophic lateral sclerosis	0.00246	0.00777	CbGeAlD
Dipyridamole—Shock—Riluzole—amyotrophic lateral sclerosis	0.00244	0.00592	CcSEcCtD
Dipyridamole—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00244	0.0059	CcSEcCtD
Dipyridamole—PDE1A—central nervous system—amyotrophic lateral sclerosis	0.00244	0.00769	CbGeAlD
Dipyridamole—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00243	0.00589	CcSEcCtD
Dipyridamole—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00242	0.00587	CcSEcCtD
Dipyridamole—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00584	CcSEcCtD
Dipyridamole—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.0024	0.00581	CcSEcCtD
Dipyridamole—PDE1A—cerebellum—amyotrophic lateral sclerosis	0.00238	0.00752	CbGeAlD
Dipyridamole—PDE2A—brain—amyotrophic lateral sclerosis	0.00233	0.00735	CbGeAlD
Dipyridamole—PDE10A—brain—amyotrophic lateral sclerosis	0.00233	0.00735	CbGeAlD
Dipyridamole—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00562	CcSEcCtD
Dipyridamole—PDE1B—brain—amyotrophic lateral sclerosis	0.00231	0.00728	CbGeAlD
Dipyridamole—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00548	CcSEcCtD
Dipyridamole—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00223	0.0054	CcSEcCtD
Dipyridamole—PDE8B—brain—amyotrophic lateral sclerosis	0.00222	0.00701	CbGeAlD
Dipyridamole—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00536	CcSEcCtD
Dipyridamole—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00534	CcSEcCtD
Dipyridamole—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00219	0.00529	CcSEcCtD
Dipyridamole—ABCC5—medulla oblongata—amyotrophic lateral sclerosis	0.00217	0.00685	CbGeAlD
Dipyridamole—PDE3B—brain—amyotrophic lateral sclerosis	0.00217	0.00685	CbGeAlD
Dipyridamole—ADA—nervous system—amyotrophic lateral sclerosis	0.00215	0.00679	CbGeAlD
Dipyridamole—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00519	CcSEcCtD
Dipyridamole—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00518	CcSEcCtD
Dipyridamole—Pain—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00514	CcSEcCtD
Dipyridamole—ADA—central nervous system—amyotrophic lateral sclerosis	0.00207	0.00654	CbGeAlD
Dipyridamole—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00495	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00492	CcSEcCtD
Dipyridamole—PDE8A—brain—amyotrophic lateral sclerosis	0.002	0.00631	CbGeAlD
Dipyridamole—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00478	CcSEcCtD
Dipyridamole—PDE4A—cerebellum—amyotrophic lateral sclerosis	0.00197	0.00623	CbGeAlD
Dipyridamole—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00475	CcSEcCtD
Dipyridamole—PDE1A—brain—amyotrophic lateral sclerosis	0.00193	0.0061	CbGeAlD
Dipyridamole—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00443	CcSEcCtD
Dipyridamole—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00431	CcSEcCtD
Dipyridamole—PDE5A—nervous system—amyotrophic lateral sclerosis	0.00178	0.00563	CbGeAlD
Dipyridamole—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00425	CcSEcCtD
Dipyridamole—PDE5A—central nervous system—amyotrophic lateral sclerosis	0.00172	0.00542	CbGeAlD
Dipyridamole—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00411	CcSEcCtD
Dipyridamole—PDE5A—cerebellum—amyotrophic lateral sclerosis	0.00168	0.00529	CbGeAlD
Dipyridamole—ADA—brain—amyotrophic lateral sclerosis	0.00164	0.00519	CbGeAlD
Dipyridamole—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00398	CcSEcCtD
Dipyridamole—PDE3A—cerebellum—amyotrophic lateral sclerosis	0.00163	0.00515	CbGeAlD
Dipyridamole—PDE4A—brain—amyotrophic lateral sclerosis	0.0016	0.00506	CbGeAlD
Dipyridamole—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00382	CcSEcCtD
Dipyridamole—Rash—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00379	CcSEcCtD
Dipyridamole—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00379	CcSEcCtD
Dipyridamole—Headache—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00377	CcSEcCtD
Dipyridamole—ABCC5—cerebellum—amyotrophic lateral sclerosis	0.00153	0.00484	CbGeAlD
Dipyridamole—SLC29A1—nervous system—amyotrophic lateral sclerosis	0.0015	0.00472	CbGeAlD
Dipyridamole—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00357	CcSEcCtD
Dipyridamole—SLC29A1—central nervous system—amyotrophic lateral sclerosis	0.00144	0.00455	CbGeAlD
Dipyridamole—SLC29A1—cerebellum—amyotrophic lateral sclerosis	0.00141	0.00445	CbGeAlD
Dipyridamole—PDE5A—brain—amyotrophic lateral sclerosis	0.00136	0.0043	CbGeAlD
Dipyridamole—PDE3A—brain—amyotrophic lateral sclerosis	0.00133	0.00418	CbGeAlD
Dipyridamole—ABCC5—brain—amyotrophic lateral sclerosis	0.00125	0.00393	CbGeAlD
Dipyridamole—SLC29A1—brain—amyotrophic lateral sclerosis	0.00114	0.00361	CbGeAlD
Dipyridamole—ABCC4—nervous system—amyotrophic lateral sclerosis	0.00113	0.00357	CbGeAlD
Dipyridamole—ABCC4—central nervous system—amyotrophic lateral sclerosis	0.00109	0.00343	CbGeAlD
Dipyridamole—ABCC4—brain—amyotrophic lateral sclerosis	0.000864	0.00273	CbGeAlD
Dipyridamole—ABCB1—embryo—amyotrophic lateral sclerosis	0.000819	0.00259	CbGeAlD
Dipyridamole—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000523	0.00165	CbGeAlD
Dipyridamole—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000467	0.00147	CbGeAlD
Dipyridamole—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000393	0.00124	CbGeAlD
Dipyridamole—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000379	0.0012	CbGeAlD
Dipyridamole—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.00037	0.00117	CbGeAlD
Dipyridamole—ABCB1—brain—amyotrophic lateral sclerosis	0.000301	0.000949	CbGeAlD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000125	0.000464	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000124	0.00046	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000124	0.00046	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000124	0.00046	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—APOE—amyotrophic lateral sclerosis	0.000124	0.00046	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000123	0.000457	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000123	0.000457	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000123	0.000455	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000123	0.000455	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000123	0.000455	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000123	0.000455	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—C3—amyotrophic lateral sclerosis	0.000123	0.000454	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000122	0.000451	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00012	0.000446	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.00012	0.000445	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000117	0.000433	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000117	0.000432	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000116	0.000428	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000116	0.000428	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000116	0.000428	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—ATF1—amyotrophic lateral sclerosis	0.000115	0.000427	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000115	0.000425	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000115	0.000425	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000115	0.000424	CbGpPWpGaD
Dipyridamole—PDE11A—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000114	0.000424	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000114	0.000422	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000113	0.000418	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000112	0.000416	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000112	0.000416	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000112	0.000414	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000112	0.000413	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000112	0.000413	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.00011	0.000407	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.00011	0.000407	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CASP9—amyotrophic lateral sclerosis	0.00011	0.000406	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.00011	0.000406	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000107	0.000397	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	0.000107	0.000396	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000107	0.000396	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000106	0.000392	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000106	0.000392	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000106	0.000391	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000106	0.000391	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—ATF1—amyotrophic lateral sclerosis	0.000105	0.00039	CbGpPWpGaD
Dipyridamole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000105	0.000388	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000105	0.000388	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000103	0.000382	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000103	0.000381	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000103	0.000381	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000102	0.000379	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000102	0.000379	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000102	0.000378	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000102	0.000378	CbGpPWpGaD
Dipyridamole—PDE5A—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000102	0.000378	CbGpPWpGaD
Dipyridamole—PDE10A—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000102	0.000378	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—CASP9—amyotrophic lateral sclerosis	0.000101	0.000375	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—CASP9—amyotrophic lateral sclerosis	0.000101	0.000375	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000101	0.000374	CbGpPWpGaD
Dipyridamole—ABCC4—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000101	0.000372	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CASP9—amyotrophic lateral sclerosis	0.0001	0.000372	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.0001	0.00037	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	9.98e-05	0.000369	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	9.67e-05	0.000358	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	9.54e-05	0.000353	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.51e-05	0.000352	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.51e-05	0.000352	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.49e-05	0.000351	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.49e-05	0.000351	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.47e-05	0.000351	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	9.41e-05	0.000348	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.4e-05	0.000348	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—ERBB4—amyotrophic lateral sclerosis	9.39e-05	0.000348	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.35e-05	0.000346	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	9.34e-05	0.000346	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	9.28e-05	0.000343	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CASP9—amyotrophic lateral sclerosis	9.27e-05	0.000343	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.25e-05	0.000342	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	9.15e-05	0.000339	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	9.15e-05	0.000339	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.11e-05	0.000337	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	9.09e-05	0.000336	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	9.08e-05	0.000336	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	8.84e-05	0.000327	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CD40LG—amyotrophic lateral sclerosis	8.83e-05	0.000327	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.82e-05	0.000327	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—VEGFA—amyotrophic lateral sclerosis	8.74e-05	0.000323	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.7e-05	0.000322	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	8.7e-05	0.000322	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	8.69e-05	0.000322	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—ERBB4—amyotrophic lateral sclerosis	8.67e-05	0.000321	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—ERBB4—amyotrophic lateral sclerosis	8.67e-05	0.000321	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—PTGS2—amyotrophic lateral sclerosis	8.63e-05	0.00032	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	8.6e-05	0.000319	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—ERBB4—amyotrophic lateral sclerosis	8.59e-05	0.000318	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.59e-05	0.000318	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.59e-05	0.000318	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	8.54e-05	0.000316	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—PTGS2—amyotrophic lateral sclerosis	8.51e-05	0.000315	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.48e-05	0.000314	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.46e-05	0.000313	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	8.45e-05	0.000313	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	8.37e-05	0.00031	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	8.29e-05	0.000307	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	8.15e-05	0.000302	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.12e-05	0.0003	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.12e-05	0.0003	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	8.11e-05	0.0003	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	8.11e-05	0.0003	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CD40LG—amyotrophic lateral sclerosis	8.08e-05	0.000299	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	7.96e-05	0.000295	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.94e-05	0.000294	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—IGF1—amyotrophic lateral sclerosis	7.94e-05	0.000294	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—ERBB4—amyotrophic lateral sclerosis	7.93e-05	0.000294	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.92e-05	0.000293	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.86e-05	0.000291	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.86e-05	0.000291	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	7.81e-05	0.000289	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—C3—amyotrophic lateral sclerosis	7.81e-05	0.000289	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.78e-05	0.000288	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.76e-05	0.000287	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—APOE—amyotrophic lateral sclerosis	7.73e-05	0.000286	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.55e-05	0.000279	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	7.48e-05	0.000277	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.45e-05	0.000276	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.43e-05	0.000275	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	7.32e-05	0.000271	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.3e-05	0.00027	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.3e-05	0.00027	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.29e-05	0.00027	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.29e-05	0.00027	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.29e-05	0.00027	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.27e-05	0.000269	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	7.23e-05	0.000268	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.19e-05	0.000266	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—C3—amyotrophic lateral sclerosis	7.14e-05	0.000264	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.12e-05	0.000263	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.1e-05	0.000263	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.09e-05	0.000263	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.01e-05	0.000259	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.9e-05	0.000256	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.9e-05	0.000256	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	6.86e-05	0.000254	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—VEGFA—amyotrophic lateral sclerosis	6.84e-05	0.000253	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.83e-05	0.000253	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	6.81e-05	0.000252	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.73e-05	0.000249	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—APOE—amyotrophic lateral sclerosis	6.71e-05	0.000248	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—APOE—amyotrophic lateral sclerosis	6.71e-05	0.000248	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.67e-05	0.000247	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.64e-05	0.000246	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	6.62e-05	0.000245	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—TP53—amyotrophic lateral sclerosis	6.6e-05	0.000244	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.51e-05	0.000241	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	6.49e-05	0.00024	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.46e-05	0.000239	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.24e-05	0.000231	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.2e-05	0.000229	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.2e-05	0.000229	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.15e-05	0.000228	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—APOE—amyotrophic lateral sclerosis	6.14e-05	0.000227	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.07e-05	0.000225	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.07e-05	0.000225	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.05e-05	0.000224	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.05e-05	0.000224	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.04e-05	0.000224	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—TP53—amyotrophic lateral sclerosis	6.01e-05	0.000223	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.89e-05	0.000218	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.72e-05	0.000212	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.72e-05	0.000212	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.71e-05	0.000211	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	5.69e-05	0.000211	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—TP53—amyotrophic lateral sclerosis	5.65e-05	0.000209	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—APOE—amyotrophic lateral sclerosis	5.62e-05	0.000208	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.61e-05	0.000208	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.56e-05	0.000206	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.53e-05	0.000205	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.52e-05	0.000204	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.52e-05	0.000204	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.51e-05	0.000204	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.51e-05	0.000204	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.49e-05	0.000203	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.39e-05	0.0002	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.37e-05	0.000199	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.3e-05	0.000196	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.3e-05	0.000196	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	5.28e-05	0.000196	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.23e-05	0.000194	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.22e-05	0.000193	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—VEGFA—amyotrophic lateral sclerosis	5.19e-05	0.000192	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—TP53—amyotrophic lateral sclerosis	5.17e-05	0.000191	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.14e-05	0.00019	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.13e-05	0.00019	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.13e-05	0.00019	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.1e-05	0.000189	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.05e-05	0.000187	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	5.01e-05	0.000186	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5e-05	0.000185	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.76e-05	0.000176	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.7e-05	0.000174	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.7e-05	0.000174	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.68e-05	0.000173	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.68e-05	0.000173	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	4.63e-05	0.000171	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.62e-05	0.000171	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—PTGS2—amyotrophic lateral sclerosis	4.6e-05	0.00017	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—PTGS2—amyotrophic lateral sclerosis	4.6e-05	0.00017	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.58e-05	0.000169	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.56e-05	0.000169	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.53e-05	0.000168	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	4.48e-05	0.000166	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.3e-05	0.000159	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.25e-05	0.000157	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PTGS2—amyotrophic lateral sclerosis	4.2e-05	0.000156	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.17e-05	0.000155	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.13e-05	0.000153	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—TP53—amyotrophic lateral sclerosis	3.92e-05	0.000145	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.88e-05	0.000144	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.88e-05	0.000144	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.88e-05	0.000144	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.85e-05	0.000143	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.8e-05	0.000141	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.6e-05	0.000133	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.55e-05	0.000131	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.55e-05	0.000131	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.49e-05	0.000129	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.46e-05	0.000128	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	3.39e-05	0.000125	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.3e-05	0.000122	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.27e-05	0.000121	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.18e-05	0.000118	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.09e-05	0.000114	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.99e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.96e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.82e-05	0.000105	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.77e-05	0.000103	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.73e-05	0.000101	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.7e-05	9.99e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.58e-05	9.56e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.54e-05	9.39e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.32e-05	8.59e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.24e-05	8.28e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.1e-05	7.76e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.04e-05	7.56e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.04e-05	7.55e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.92e-05	7.09e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.88e-05	6.95e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.75e-05	6.49e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	1.54e-05	5.72e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.06e-05	3.92e-05	CbGpPWpGaD
